These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report.
    Author: Yeh AW, Lee JW, Cheng TC, Wen JK, Chen WH.
    Journal: Clin Neuropharmacol; 2004; 27(5):216-8. PubMed ID: 15602101.
    Abstract:
    Catatonia as a clozapine withdrawal syndrome has not been well documented. There is only 1 case of excited catatonia described with the diagnosis made according to strict criteria. The authors report a patient who developed a catatonic stuporous state following abrupt discontinuation of clozapine, associated with features of cholinergic and serotonergic hyperactivity. The catatonic state resolved within 1 week with reinstatement of clozapine. It is suggested that serotonergic hyperactivity was involved, contributed by cholinergic rebound, in the pathogenesis of this patient's clozapine withdrawal catatonic syndrome.
    [Abstract] [Full Text] [Related] [New Search]